Monday, November 30, 2015 3:12:04 PM
Subject: Imaging3 Newsletter
Priority: Normal Date: Monday, November 30, 2015 1:48 PM Size: 26 KB
a little late but I got it
alt imaging3_tagline.gif
Imaging3, Inc. Announces 2012-2013, 2103-2014, 10K’s completed.
Imaging3™, Inc. announces today that it has finalized and filed its 2012-13 and 2013-14 10Ks with the Securities and Exchange Commission. The company’s financials were audited by Rose, Snyder & Jacobs LLP, which is located in Encino, California.
We will now focus on completing all required quarterly financials and will make an announcement upon their completion.
Dane Medley, President and CEO of Imaging3, stated, “The completion of these annual financial reports is a great step in getting the company back on solid ground. It has taken a collaboration of many individuals and business partners working diligently towards the same goals. We are working on several other business initiatives that we hope will increase our revenues and bring value to our investors.”
About Imaging3
Imaging3, Inc., founded in 1993, has developed a medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time. Because these 3D images are instantly constructed in real-time, they can be used for any current or new medical procedures in which multiple frames of reference are required to perform medical procedures on or in the human body. Visit the company’s website at http://www.imaging3.com for more information
Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, technological obsolescence, competition from other medical instrument(s) and imaging companies, lack of capital, unexpected costs, failure or delay of FDA approval, failure to obtain a trading symbol from FINRA, failure to consummate desired business combinations or transactions, delays or adverse rulings relating to its pending Chapter 11 bankruptcy action, absence of revenue, the impact on the national and local economies resulting from an economic recession or terrorist actions, and U.S. actions subsequently; unavailability of financing for the Company or its customers, product malfunction, potential product liability claims, and other factors detailed in reports filed by the Company. Imaging3 cannot assure that it will obtain regulatory approval for the Dominion VI Scanner or any other products, successfully complete the Chapter 11 bankruptcy process, successfully complete its financial statements, or obtain a trading symbol from FINRA.
Contact:
Imaging3, Inc.
Investor Relations
800-900-9729
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM